C32H32F4N8O2S2 — CID 123530927
2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[3-[5-[[2-[3-(3,3-difluoroazetidin-1-yl)phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]acetamide (PubChem CID 123530927) has the molecular formula C32H32F4N8O2S2 and a molecular weight of 700.79 g/mol. Its IUPAC name is 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[3-[5-[[2-[3-(3,3-difluoroazetidin-1-yl)phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]acetamide.
| Compound Name | 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[3-[5-[[2-[3-(3,3-difluoroazetidin-1-yl)phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]acetamide |
|---|---|
| PubChem CID | 123530927 |
| Molecular Formula | C32H32F4N8O2S2 |
| Molecular Weight | 700.79 g/mol |
| Exact Mass | 700.20 |
| IUPAC Name | 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[3-[5-[[2-[3-(3,3-difluoroazetidin-1-yl)phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]acetamide |
| SMILES | O=C(Cc1cccc(N2CC(F)(F)C2)c1)Nc1nnc(C2CCCC(c3nnc(NC(=O)Cc4cccc(N5CC(F)(F)C5)c4)s3)C2)s1 |
| InChI | InChI=1S/C32H32F4N8O2S2/c33-31(34)15-43(16-31)23-8-1-4-19(10-23)12-25(45)37-29-41-39-27(47-29)21-6-3-7-22(14-21)28-40-42-30(48-28)38-26(46)13-20-5-2-9-24(11-20)44-17-32(35,36)18-44/h1-2,4-5,8-11,21-22H,3,6-7,12-18H2,(H,37,41,45)(H,38,42,46) |
| InChIKey | WPKZWBBGFNHOFH-UHFFFAOYSA-N |
| XLogP | 6.10 |
| TPSA | 116.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 48 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 700.79 |
| LogP ≤ 5 | 6.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |